Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-02-25 @ 6:56 PM
Study NCT ID:
NCT01700751
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2012-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2015-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-18
First Submit QC Date:
None
Study First Post Date:
2012-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-12
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL